George Kurdgelashvili MD (He/Him)
Hospital Medicine/Hospitalist, Infectious Disease
Chief of Medicine Oklahoma City VA Healthcare System Clinical Professor, Dept of Medicine, University of Oklahoma College of Medicine
Join to View Full Profile
921 NE 13th street 111 COklahoma City, OK 73104
Phone+1 405-456-1000
Dr. Kurdgelashvili is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Infectious Disease, 2002 - 2004
Emory University School of MedicineResidency, Internal Medicine, 1999 - 2002
Tbilisi State Medical UniversityClass of 1996
Certifications & Licensure
OK State Medical License 2002 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- VA CoronavirUs Research and Efficacy Studies-1 Start of enrollment: 2020 Nov 16
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Roles: Contact
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Start of enrollment: 2018 Jan 22
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsCharacteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents.Chris A Gentry, Phoi N Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams 2nd
Clinical Infectious Diseases. 2024-02-17 - 12 citationsCharacteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.Chris A Gentry, Phoi Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams
The Journal of Infection. 2023-03-01 - Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: A retrospective,...Chris A Gentry, Sharanjeet K Thind, Riley J Williams 2nd, Sage C Hendrickson, George Kurdgelashvili
The American Journal of the Medical Sciences. 2023-01-01
Press Mentions
HPV-related cancers rose before vaccines hit marketApril 27th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
